DISPERSYN GERRIT (Chief Development Officer) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/5/2019ACC: 0001209191-19-017201
Officer· Chief Development Officer
Since Aug 2018
+407.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
407.70K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+407.70K
Price / share
—
Trade value
—
% of position
571.4%
3/1/2019
71.35K→479.05K
Total
Net shares
+407.70K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2019 | A · Award | +407.70K | — | — | 571.4% | 71.35K | 479.05K |
| Total | +407.70K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported